Leaving aside that it is ridiculous to think that clinical trials done by drug manufacturers with a vested interest are the definitive evidence of drug efficacy and safety; it is widespread knowledge that drugs in clinical use rarely reach the efficacy or the safety results seen in trials.
And leaving aside that the VAERS data that you disparge is the exact data the the CDC uses to examine safety when the drug is in clinical use.
I have read all the covid vaccine briefing books. The trials deliberately limited the enrollment of people over 75 which is a common thing to do in a clinical trial for obvious reasons.
The following is from JAMA. (JAMA: The Journal of the American Medical Association is a peer-reviewed medical journal published 48 times a year by the American Medical Association. It publishes original research, reviews, and editorials covering all aspects of biomedicine.”)
“Our findings indicate that older adults are likely to be excluded from more than 50% of COVID-19 clinical trials and 100% of vaccine trials. Such exclusion will limit the ability to evaluate the efficacy, dosage, and adverse effects of the intended treatments. We acknowledge that some exclusions for severe or uncontrolled comorbidities will be essential to protect the health and safety of older adults. However, caution must be taken to avoid excluding otherwise eligible participants for reasons that are not well-justified.
“Even without stated age-based exclusions, several recently published clinical trials of COVID-19 treatments had young age ranges, such as 1 recent study4 with a median age of only 40 years, meaning there would be no or few participants over age 75.
“If the older age group is excluded from vaccine trials, efforts to ensure effectiveness, titrate dosage or frequency, and assess adverse effects in the group most vulnerable to COVID-19 will not be possible.”
Let me share with you some of that data from the clinical trials that you hold in such high regard. The following is from Moderna COVID-19 Vaccine VRBPAC Briefing Document
“The small number participants and cases in some subgroups, such as participants >75 years of age and
participants in certain racial subgroups, limits the interpretability of the individual VE results, but
are displayed for completeness.”
Did you look at the results of the real-world example in Israel that I posted? It showed 94% to 96% efficacy across all age groups who got it.
...the VAERS data that you disparge is the exact data the the CDC uses to examine safety when the drug is in clinical use.
Nonsense. At best it serves as an alert system to tell the CDC to examine more deeply. They then do detailed case-by-case reviews to evaluate safety. They would be nuts to rely on VAERS as anything more reliable than an internet poll.
The trials deliberately limited the enrollment of people over 75 which is a common thing to do in a clinical trial for obvious reasons.
Can you point me to a reference for this?
The fact that there weren't too many people in the Moderna study over 75 means what to you?
Again, what's the point of all this data lawyering?
The vaccines have been shown in trials and proven in real life applications to be both safe and effective for adult populations, including those over 75. Do you think seniors should take the vaccine, and if not, why not?